Creo Medical (GB:CREO) has released an update.
Creo Medical Group plc, a leader in minimally invasive surgical endoscopy, has been honored with the prestigious King’s Award for Enterprise in Innovation. The company’s flagship technology, the Speedboat device, leverages its advanced CROMA platform to perform surgeries from within the body, offering significant patient benefits and cost savings. The recognition reflects Creo’s impact on healthcare innovation, with their devices already enhancing patient outcomes and efficiency in over 20 NHS hospitals.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
Click Here to Read the Full Original Article at TipRanks Financial Blog…
